The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Electrocompetent Cells-Global Market Insights and Sales Trends 2024
Synopsis
Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
The global Electrocompetent Cells market size is expected to reach US$ 1335.4 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Electrocompetent Cells in various end use industries. The expanding demands from the Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning and High-Throughput Cloning, are propelling Electrocompetent Cells market. Cloned Competent Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agrobacterium tumefaciens Competent Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Electrocompetent Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the Electrocompetent Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Electrocompetent Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Electrocompetent Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Electrocompetent Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Electrocompetent Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Electrocompetent Cells covered in this report include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
The global Electrocompetent Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Global Electrocompetent Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Electrocompetent Cells market, Segment by Type:
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Global Electrocompetent Cells market, by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Electrocompetent Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
The global Electrocompetent Cells market size is expected to reach US$ 1335.4 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Electrocompetent Cells in various end use industries. The expanding demands from the Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning and High-Throughput Cloning, are propelling Electrocompetent Cells market. Cloned Competent Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agrobacterium tumefaciens Competent Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Electrocompetent Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the Electrocompetent Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Electrocompetent Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Electrocompetent Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Electrocompetent Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Electrocompetent Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Electrocompetent Cells covered in this report include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
The global Electrocompetent Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Global Electrocompetent Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Electrocompetent Cells market, Segment by Type:
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Global Electrocompetent Cells market, by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Electrocompetent Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Electrocompetent Cells
1.1 Electrocompetent Cells Market Overview
1.1.1 Electrocompetent Cells Product Scope
1.1.2 Electrocompetent Cells Market Status and Outlook
1.2 Global Electrocompetent Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Electrocompetent Cells Market Size by Region (2018-2029)
1.4 Global Electrocompetent Cells Historic Market Size by Region (2018-2023)
1.5 Global Electrocompetent Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Electrocompetent Cells Market Size (2018-2029)
1.6.1 North America Electrocompetent Cells Market Size (2018-2029)
1.6.2 Europe Electrocompetent Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Electrocompetent Cells Market Size (2018-2029)
1.6.4 Latin America Electrocompetent Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Electrocompetent Cells Market Size (2018-2029)
2 Electrocompetent Cells Market by Type
2.1 Introduction
2.1.1 Cloned Competent Cells
2.1.2 Agrobacterium tumefaciens Competent Cells
2.1.3 Expression Competent Cells
2.2 Global Electrocompetent Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Electrocompetent Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Electrocompetent Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Electrocompetent Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Electrocompetent Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Electrocompetent Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Electrocompetent Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Electrocompetent Cells Revenue Breakdown by Type (2018-2029)
3 Electrocompetent Cells Market Overview by Application
3.1 Introduction
3.1.1 Subcloning & Routine Cloning
3.1.2 Phage Display Library Construction
3.1.3 Toxic/Unstable Dna Cloning
3.1.4 High-Throughput Cloning
3.1.5 Protein Expression
3.1.6 Mutagenesis
3.1.7 Single-Stranded Dna Production
3.1.8 Bacmid creation
3.1.9 Cre-lox recombination (PIR1/PIR2)
3.2 Global Electrocompetent Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Electrocompetent Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Electrocompetent Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Electrocompetent Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Electrocompetent Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Electrocompetent Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Electrocompetent Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Electrocompetent Cells Revenue Breakdown by Application (2018-2029)
4 Electrocompetent Cells Competition Analysis by Players
4.1 Global Electrocompetent Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2022)
4.3 Date of Key Players Enter into Electrocompetent Cells Market
4.4 Global Top Players Electrocompetent Cells Headquarters and Area Served
4.5 Key Players Electrocompetent Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Electrocompetent Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Profile
5.1.2 Merck KGaA Main Business
5.1.3 Merck KGaA Electrocompetent Cells Products, Services and Solutions
5.1.4 Merck KGaA Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Electrocompetent Cells Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Electrocompetent Cells Products, Services and Solutions
5.3.4 Agilent Technologies Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Takara Bio Recent Developments
5.4 Takara Bio
5.4.1 Takara Bio Profile
5.4.2 Takara Bio Main Business
5.4.3 Takara Bio Electrocompetent Cells Products, Services and Solutions
5.4.4 Takara Bio Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Takara Bio Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Profile
5.5.2 Promega Corporation Main Business
5.5.3 Promega Corporation Electrocompetent Cells Products, Services and Solutions
5.5.4 Promega Corporation Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Corporation Recent Developments
5.6 Beijing TransGen Biotech
5.6.1 Beijing TransGen Biotech Profile
5.6.2 Beijing TransGen Biotech Main Business
5.6.3 Beijing TransGen Biotech Electrocompetent Cells Products, Services and Solutions
5.6.4 Beijing TransGen Biotech Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Beijing TransGen Biotech Recent Developments
5.7 GeneScript Corporation
5.7.1 GeneScript Corporation Profile
5.7.2 GeneScript Corporation Main Business
5.7.3 GeneScript Corporation Electrocompetent Cells Products, Services and Solutions
5.7.4 GeneScript Corporation Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.7.5 GeneScript Corporation Recent Developments
5.8 Yeastern Biotech
5.8.1 Yeastern Biotech Profile
5.8.2 Yeastern Biotech Main Business
5.8.3 Yeastern Biotech Electrocompetent Cells Products, Services and Solutions
5.8.4 Yeastern Biotech Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Yeastern Biotech Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs Electrocompetent Cells Products, Services and Solutions
5.9.4 New England Biolabs Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 QIAGEN N.V.
5.10.1 QIAGEN N.V. Profile
5.10.2 QIAGEN N.V. Main Business
5.10.3 QIAGEN N.V. Electrocompetent Cells Products, Services and Solutions
5.10.4 QIAGEN N.V. Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN N.V. Recent Developments
5.11 OriGene Technologies
5.11.1 OriGene Technologies Profile
5.11.2 OriGene Technologies Main Business
5.11.3 OriGene Technologies Electrocompetent Cells Products, Services and Solutions
5.11.4 OriGene Technologies Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.11.5 OriGene Technologies Recent Developments
5.12 Lucigen
5.12.1 Lucigen Profile
5.12.2 Lucigen Main Business
5.12.3 Lucigen Electrocompetent Cells Products, Services and Solutions
5.12.4 Lucigen Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Lucigen Recent Developments
5.13 Zymo Research
5.13.1 Zymo Research Profile
5.13.2 Zymo Research Main Business
5.13.3 Zymo Research Electrocompetent Cells Products, Services and Solutions
5.13.4 Zymo Research Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Zymo Research Recent Developments
5.14 Bio-Rad Laboratories
5.14.1 Bio-Rad Laboratories Profile
5.14.2 Bio-Rad Laboratories Main Business
5.14.3 Bio-Rad Laboratories Electrocompetent Cells Products, Services and Solutions
5.14.4 Bio-Rad Laboratories Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Bio-Rad Laboratories Recent Developments
5.15 Bioline
5.15.1 Bioline Profile
5.15.2 Bioline Main Business
5.15.3 Bioline Electrocompetent Cells Products, Services and Solutions
5.15.4 Bioline Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Bioline Recent Developments
5.16 Delphi Genetics
5.16.1 Delphi Genetics Profile
5.16.2 Delphi Genetics Main Business
5.16.3 Delphi Genetics Electrocompetent Cells Products, Services and Solutions
5.16.4 Delphi Genetics Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Delphi Genetics Recent Developments
5.17 IBA GmBH
5.17.1 IBA GmBH Profile
5.17.2 IBA GmBH Main Business
5.17.3 IBA GmBH Electrocompetent Cells Products, Services and Solutions
5.17.4 IBA GmBH Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.17.5 IBA GmBH Recent Developments
5.18 Cell Applications
5.18.1 Cell Applications Profile
5.18.2 Cell Applications Main Business
5.18.3 Cell Applications Electrocompetent Cells Products, Services and Solutions
5.18.4 Cell Applications Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.18.5 Cell Applications Recent Developments
5.19 BioDynamics Laboratory
5.19.1 BioDynamics Laboratory Profile
5.19.2 BioDynamics Laboratory Main Business
5.19.3 BioDynamics Laboratory Electrocompetent Cells Products, Services and Solutions
5.19.4 BioDynamics Laboratory Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.19.5 BioDynamics Laboratory Recent Developments
5.20 Scarab Genomics
5.20.1 Scarab Genomics Profile
5.20.2 Scarab Genomics Main Business
5.20.3 Scarab Genomics Electrocompetent Cells Products, Services and Solutions
5.20.4 Scarab Genomics Electrocompetent Cells Revenue (US$ Million) & (2018-2023)
5.20.5 Scarab Genomics Recent Developments
6 North America
6.1 North America Electrocompetent Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Electrocompetent Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Electrocompetent Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Electrocompetent Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Electrocompetent Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Electrocompetent Cells Market Dynamics
11.1 Electrocompetent Cells Industry Trends
11.2 Electrocompetent Cells Market Drivers
11.3 Electrocompetent Cells Market Challenges
11.4 Electrocompetent Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
